Tetrafungin, a new polyene macrolide antibiotic, is produced by a Streptomyces strain identified as a new subspecies of Streptomyces albulus and named Streptomyces albulus subsp. tetrafungini. Tetrafungin and nystatin have been investigated and compared by HPLC. It has been demonstrated that tetrafungin and nystatin differ qualitatively in, at least, one component, and quantitatively in their relative amounts of common components.
As described in the preceding papery, tetrafungin is a new antifungal antibiotic produced by a Streptomyces strain.
Its UV absorption spectrum and its physico-chemical characteristics place this antibiotic in the tetraene group of polyene macrolide (2.2.2.3 of the BERDY2) classification). Since most polyene antibiotics are found to be mixtures of closely related homologs, an efficient analytical procedure is necessary to obtain a good characterization of these compounds. Several procedures have been used for this purpose and HPLC has previously been shown to be the most useful3-6). The present report describes the taxonomic characterization of the producing strain of tetrafungin as well as a comparative study between tetrafungin and nystatin by HPLC.
Material and Methods

Taxonomy
The methods and media recommended by the International Streptomyces Project) were used primarily, along with several supplementary tests. The procedure of BECKER et al. 8 ) was used for the preparation of cells and chromatographic detection of the isomers of diaminopimelic acid. Tetrafungin (E1%1cm 825 at 305 nm) obtained as described previously1) and two different samples of nystatin, nystatin 1 (Squibb lot 55317-098, E. R. Squibb, New Brunswick, N. J.), and nystatin 2 (Sigma lot 95C-0209, Sigma Chem. Co., Saint Louis, Missouri), were used as pure samples. Standards of these antibiotics for HPLC were prepared by dissolving 10 mg of each sample in I ml of dimethyl sulfoxide (Merck) and diluting the solution with 9 ml of methanol (Merck) to a final concentration of 1 mg/ml. Higher dilutions were made by adding more methanol.
The non-purified tetrafungin samples for HPLC were obtained as follows: the Streptomyces strain No. 67 was grown in a 50-m1 Erlenmeyer flask containing 15 ml of fermentation medium1) for 72 hours at 28°C on a rotary shaker running at 300 rpm. After incubation, the cells were collected by centrifugation from 10 ml of fermented culture. Tetrafungin was extracted from the pellet with 10 ml of methanol (Merck) as described previously'). This methanolic extract without further treatment was used as a non-purified sample of tetrafungin.
Before injection, all samples were filtered throught a Millipore membrane filter (pore size: 0.5um; Millipore Co., Bedford, Mass.,). Injected volumes were 10 and 20 pl containing 2.5-10 pg of the antibiotic.
Instrument Operation: After achieving equilibrium in the instruments, demonstrated by a constant base line on the recorder, the samples were applied. The chart speed in both recorders was constant at 0.5 cm/minute. During chromatography, the columns were operated at room temperature. In apparatus B the detector wavelength was selected to be 305 nm. Other operating conditions are shown in the results.
At the end of each working day, the columns should be rinsed with methanol for about 30 minutes.
Results and Discussion
The producing organism, strain No. 67, produces a vegetative mycelium which does not fragment into coccoid or bacillary elements, and an aerial mycelium, which later forms spore chains. The cultural and summarized physiological properties are shown in Tables 1 and 2 In our studies, when apparatus A was employed, optimal separations were achieved using 70
(v/v) methanol as the mobile phase. An increase in methanol concentration reduced the retention times, making the separation difficult. When the methanol concentration was reduced, the peaks became very broad and the retention times increased. The chromatograms obtained with 70% (v/v) methanol show qualitative and quantitative differences between tetrafungin and nystatin. Peak 2 -the main component of tetrafungin -is absent or in a non-detectable amount in nystatin. On the other hand, peak 1 -the main component of nystatin -appears as a minor component in tetrafungin. The chromatograms of the two commercial nystatin samples from two different producers were found to be practically identical ( Fig. 1 ) and no significative differences are to be seen. Although in isocratic conditions the MicroPak MCH-10 column equipping apparatus B was poorer in resolution capacity than the LiChrosorb RP-8 column equipping apparatus A, new components in both tetrafungin and nystatin, in addition to those described above, were detected by using a gradient elution. The selected gradient elution profile was the following: 60°,0 (v/v) methanol was maintained (Fig. 3) . The presence of a heptaene in nystatin has been shown by previous workers5).
From this study, it may be deduced that tetrafungin and nystatin are closely related complex antibiotics: Both antibiotics are produced by strains belonging to S. albulas; both antibiotics contain a minor heptaenic component detectable by spectroscopic UV analysis; in both antibiotics component 4 is present, and perhaps also component 3; main component of nystatin (presumably nystatin A1 or a mixture of Al and A2 and/or A3) is present in tetrafungin as a minor component.
However nystatin and tetrafungin are different, since besides quantitative differences in their common components, these antibiotics differ qualitatively in, at least, one main component. Similarly, polifungin and nystatin complexes were differentiated from each other by the presence of a minor component in polifungin which is absent in nystatin, though no differences were found in their main components14). HPLC studies involving closely related heptaene macrolide antibiotics' also indicated that many of them have numerous common components but differ in their relative amounts and/or in the presence of additional components. 
